NCT01503515 2024-10-16
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant
Children's Oncology Group
Phase 3 Completed
Clinical Trials
6 trialsNCT00075803 2023-01-04
BMT CTN 0101
Medical College of Wisconsin
Phase 3 Completed
NCT00893555 2017-01-12
VORI911
University Medical Center Groningen
Phase 3 Completed
NCT00904995 2012-08-07
Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00015665 2008-03-04
Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections
National Institutes of Health Clinical Center (CC)
Phase 3 Completed
NCT00152594 2006-11-14
Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia
University of Cologne
Phase 3 Terminated